Talis Biomedical Corporation

TLIS

TLISTalis Biomedical Corporation US flag

Other OTC

2.84

USD

- -

5.18MMarket Cap

Income Statement (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	4	- -
+ Sales & Services Revenue	- -	- -	- -	- -	4	- -
- Cost of Revenue	- -	- -	- -	- -	8	- -
+ Cost of Goods & Services	- -	- -	- -	- -	8	- -
Gross Profit	- -	- -	- -	- -	-5	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -
- Operating Expenses	21	27	91	192	110	67
+ Selling, General & Admin	5	7	13	42	41	28
+ Research & Development	18	24	89	158	71	41
+ Other Operating Expense	-2	-4	-11	-8	-1	-2
Operating Income (Loss)	-21	-27	-91	-192	-115	-67
- Non-Operating (Income) Loss	- -	1	- -	- -	-2	-5
+ Interest Expense, Net	- -	- -	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	1	- -	- -	-2	-5
Pretax Income	-21	-27	-91	-192	-113	-62
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-21	-27	-91	-192	-113	-62
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-21	-27	-91	-192	-113	-62
- Minority Interest	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-21	-27	-91	-192	-113	-62
- Preferred Dividends	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-21	-27	-91	-192	-113	-62
EBIT	-21	-27	-91	-192	-115	-67
EBITDA	-21	-26	-90	-190	-106	-66
EBITDA Margin (%)	- -	- -	- -	- -	-2,910.98	-16,030.34
EBITA	-21	-27	-91	-192	-115	-67
Gross Margin (%)	- -	- -	- -	- -	-129.76	90.05
Operating Margin (%)	- -	- -	- -	- -	-3,152.77	-16,217.23
Profit Margin (%)	- -	- -	- -	- -	-3,094.52	-15,050.24
Sales per Employee	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Depreciation Expense	1	1	1	2	9	1
Basic Weighted Avg Shares	- -	- -	1	2	2	2
Basic EPS, GAAP	-141.85	-94.51	-69.46	-109.08	-63.26	-34.12
Basic EPS from Cont Ops	-141.85	-94.51	-69.46	-109.08	-63.26	-34.12
Diluted Weighted Avg Shares	- -	- -	1	2	2	2
Diluted EPS, GAAP	-141.85	-94.51	-69.46	-109.08	-63.26	-34.12
Diluted EPS from Cont Ops	-141.85	-94.51	-69.46	-109.08	-63.26	-34.12

Balance Sheet (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	9	24	189	236	133	78
+ Cash, Cash Equivalents & STI	7	22	138	233	130	77
+ Cash & Cash Equivalents	7	22	138	233	130	77
+ ST Investments	- -	- -	- -	- -	- -	- -
+ Accounts & Notes Receiv	2	2	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	2	2	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	1	50	3	3	1
+ Misc ST Assets	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	2	2	10	30	36	17
+ Property, Plant & Equip, Net	2	2	10	23	34	15
+ Property, Plant & Equip	3	4	13	27	47	28
- Accumulated Depreciation	2	2	3	4	13	13
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	6	2	2
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	6	2	2
Total Assets	11	26	198	266	169	95
+ Payables & Accruals	2	2	11	10	5	2
+ Accounts Payable	2	2	5	5	4	1
+ Accrued Taxes	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	6	5	1	1
+ ST Debt	- -	- -	1	1	4	3
+ ST Borrowings	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	1	1	4	3
+ Other ST Liabilities	2	2	4	7	4	4
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	2	2	4	7	4	4
Total Current Liabilities	3	4	16	19	13	9
+ LT Debt	- -	- -	- -	13	30	17
+ LT Borrowings	- -	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	13	30	17
+ Other LT Liabilities	60	43	291	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	60	43	291	- -	- -	- -
Total Noncurrent Liabilities	60	43	291	13	30	17
Total Liabilities	63	47	307	32	43	26
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	2	61	64	599	605	609
+ Common Stock	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	2	61	64	599	605	609
- Treasury Stock	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-54	-82	-173	-365	-478	-540
+ Other Equity	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-52	-21	-109	234	127	69
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -
Total Equity	-52	-21	-109	234	127	69
Total Liabilities & Equity	11	26	198	266	169	95
Shares Outstanding	1	1	1	2	2	2
Number of Employees	- -	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	1	14	34	20
Net Debt	-7	-22	-138	-233	-130	-77
Net Debt to Equity	13.26	102.19	127.55	-99.39	-102.72	-111.02
Tangible Common Equity Ratio	-457.04	-82.15	-54.72	88.02	74.86	73
Current Ratio	2.77	5.97	11.77	12.36	10.52	8.86
Cash Conversion Cycle	- -	- -	- -	- -	-168.82	-22,573.8

Cash Flow Statement (USD)

API Chat

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-21	-27	-91	-192	-113	-62
+ Depreciation & Amortization	1	1	1	2	9	1
+ Non-Cash Items	1	2	4	10	12	11
+ Stock-Based Compensation	1	1	4	9	5	4
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	4	3
+ Other Non-Cash Adj	- -	1	1	1	3	4
+ Chg in Non-Cash Work Cap	-1	1	-1	9	-8	-3
+ (Inc) Dec in Accts Receiv	-2	- -	1	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	-12	12	1	2
+ Inc (Dec) in Accts Payable	1	1	10	2	-9	-6
+ Inc (Dec) in Other	- -	- -	-1	-6	1	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-21	-24	-87	-171	-100	-53
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	-1	-1	-8	-3	-2	- -
+ Acq of Fixed Prod Assets	-1	-1	-8	-3	-2	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	233	- -	- -
+ Increase in Capital Stock	- -	- -	- -	233	- -	- -
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	-1	-1	-8	-3	-2	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	15	- -	- -	- -	- -
+ Cash From Debt	- -	15	- -	- -	- -	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	25	247	2	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	40	247	234	- -	- -
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -
Net Changes in Cash	-21	15	152	60	-101	-54
EBITDA	-21	-26	-90	-190	-106	-66
EBITDA Margin (%)	- -	- -	- -	- -	-2,910.98	-16,030.34
Free Cash Flow	-21	-25	-95	-174	-102	-54
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-10	-95	-174	-102	-54
Free Cash Flow per Basic Share	-142.77	-85.67	-72.58	-98.98	-56.96	-29.56
Price/Free Cash Flow	- -	- -	- -	-0.63	-0.12	-0.26
Cash Flow to Net Income	0.98	0.89	0.95	0.89	0.89	0.86
Capital Expenditures	-1	-1	-8	-3	-2	- -